Category IP-Watch Briefs

EuroDIG 2016: Multi-Stakeholder Soul-Searching

Some 800 registered participants gathered for the European Dialogue on Internet Governance (EuroDIG) in Brussels today to talk about internet privacy, security and access. Besides the topical issues, the opening sessions speakers came back time and again to the discrepancy of theory and practice of the much-belaboured “multi-stakeholder principle.”

Initiative To Find New Antibiotics Launched At WHA

A new initiative seeking to develop new antibiotic treatments is being launched today at the annual World Health Assembly. The Global Antibiotic Research and Development (GARD) is a partnership between the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi).

Ways To Follow The #WHA69 Opening Today

The 69th World Health Assembly (WHA) opens today in Geneva, with well over 3,000 participants and a record number of agenda items. For the 12th consecutive year, Intellectual Property Watch has a dedicated team on the ground, bringing you informed, timely reports on the action, on the floor and behind the scenes. Below are some other ways to follow the action as well, including a handy list of Twitter hashtags for the week.

ICTSD: Specialised Intellectual Property Courts – Issues And Challenges

The establishment of the WTO Agreement on TRIPS (Trade Related Aspects of Intellectual Property Rights) and the proliferation of plurilateral, bilateral and regional agreements have significantly contributed to the increasing complexities of the intellectual property system. The emergence of new actors, reflecting conflicting expectations and the adoption of new trade agreements that often exceed the standards set by the TRIPS agreement, have resulted in a new density of rules that have further fragmented the international system. These developments have unavoidably called for further analysis by academics and stakeholders.

Washington Post- Colombia Battles World’s Biggest Drugmaker Over Cancer Drug

[From the Washington Post] BOGOTA, Colombia — Colombia’s government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.

USITC Finds TPP Benefits US Economy, But Maybe Not Jobs; Unclear On IP Rights

The United States International Trade Commission (ITC), an independent government agency, today released an 800-page analysis of the economic impact of the Trans-Pacific Partnership (TPP) Agreement completed last year.